Spermatogenesis

Open a single human testis and uncoil its seminiferous tubules and you would have nearly 300 metres of microscopic tubing, all of it dedicated to one task: converting a small reserve of stem cells into a relentless stream of sperm. Spermatogenesis is that conversion. Unlike most organs, which finish developing and then merely maintain themselves, the testis runs a full developmental program — stem-cell renewal, two reductive divisions, and a dramatic cellular makeover — over and over, every day, for the whole of adult life. The reward for this complexity is a haploid cell small enough to swim and accurate enough to carry an intact genome into the next generation.

The seminiferous tubule and its cast

Each seminiferous tubule is a tube whose wall is a stratified epithelium. The outermost layer, resting on the basement membrane, holds the spermatogonia — the diploid germ-cell stem pool. As cells differentiate, they climb toward the central lumen, so the cross-section reads like a timeline from outside (youngest) to inside (most mature). Threaded through the whole wall are tall, columnar Sertoli cells, each one a nurse that physically embeds dozens of developing germ cells, feeds them, phagocytoses their discarded cytoplasm, and reads the hormonal signals that pace the whole process. A man has only a fixed number of Sertoli cells set during childhood, and that number caps his maximum sperm output.

Between the tubules sit the Leydig cells, the endocrine engine. They make testosterone in response to luteinising hormone, and they pour it into the interstitium and into the tubules, where it reaches concentrations 50 to 100 times higher than in the bloodstream. This local androgen flood — not the serum level — is what permits meiosis to finish. The distinction matters clinically: a man on testosterone replacement or anabolic steroids has high blood testosterone but a collapsed intratesticular level, because his own pituitary drive has been switched off.

The three acts: mitosis, meiosis, metamorphosis

Spermatogenesis divides cleanly into three phases. First, the mitotic (proliferative) phase: type A spermatogonia divide to both renew the stem pool and produce type B spermatogonia committed to differentiation. This is the only stage that keeps the supply line stocked, so its stem cells are the ones that must survive an insult for fertility to recover.

Second, the meiotic phase. A type B spermatogonium grows into a primary spermatocyte and enters meiosis. Meiosis I is long — its prophase, where homologous chromosomes pair and cross over, can last weeks — and ends by splitting the diploid primary spermatocyte into two haploid secondary spermatocytes. Meiosis II follows quickly, separating sister chromatids to yield four haploid round spermatids from each starting primary spermatocyte. Crossing over here is the source of genetic recombination; errors here are the source of aneuploid sperm.

Third, spermiogenesis: the round spermatid, which still looks like an ordinary cell, metamorphoses into a streamlined spermatozoon without any further division. The Golgi apparatus builds the acrosome, an enzyme-loaded cap over the nucleus that will later drill into the egg. The centriole grows a flagellum. Mitochondria spiral into the midpiece to power that tail. The nucleus condenses tenfold as histones are swapped for tightly packing protamines, and the cytoplasm is jettisoned as a residual body that Sertoli cells eat. The finished cell is released into the lumen in a step called spermiation.

A crucial and counterintuitive detail: throughout all of this, the dividing germ cells never fully separate. Cytokinesis is incomplete, leaving them joined by cytoplasmic bridges in a syncytium. This lets the haploid cells share gene products from both parental sets of chromosomes, so a spermatid carrying only an X or only a Y still develops normally. It also synchronises maturation, which is why the tubule shows organised waves rather than chaos.

The numbers that matter

The defining number is time. The full cycle is fixed at about 64 days, followed by roughly 10 to 14 days of transit and maturation in the epididymis, where sperm finally gain progressive motility and the ability to fertilise. This fixed clock is clinically powerful: anything that damages the line — high fever, a course of chemotherapy, a scrotal injury, a sauna habit — does not show up in the ejaculate until about three months later, and recovery is delayed by the same lag. It is also why guidelines repeat an abnormal semen analysis after about 90 days before acting on it.

Output is the next headline figure: a healthy adult produces on the order of 100 to 300 million sperm per day, which works out to over a thousand per second. The WHO 2021 reference lower limits, derived from men who fathered a child within 12 months, are a concentration of at least 16 million per millilitre, a total of at least 39 million per ejaculate, at least 42% total motility, and at least 4% normal morphology. These are population fifth-percentiles, not sterility thresholds, and many men below them conceive naturally.

The blood-testis barrier and immune privilege

Tight junctions between adjacent Sertoli cells split the tubule into two compartments and form the blood-testis barrier. The basal compartment holds spermatogonia and early spermatocytes; the adluminal compartment holds the later, haploid cells. The barrier matters because haploid germ cells display surface proteins the immune system never encountered before puberty and would treat as foreign. Sequestering them makes the testis immune-privileged. When that barrier is breached — by vasectomy, torsion, trauma, or infection — the immune system can form anti-sperm antibodies, which is one mechanism of post-vasectomy and post-traumatic infertility, and a reason vasectomy reversal does not always restore fertility.

Clinical correlations

• Hypogonadism. Primary (testicular) failure such as Klinefelter syndrome (47,XXY) raises FSH and LH but drops sperm output; secondary (pituitary/hypothalamic) failure as in Kallmann syndrome lowers all of them. The FSH/LH pattern tells you where the lesion sits.
• Exogenous androgens. Testosterone therapy and anabolic steroids suppress GnRH, FSH, and LH, collapsing intratesticular testosterone and causing reversible azoospermia — a leading and under-recognised cause of male infertility.
• Varicocele. Dilated scrotal veins raise testicular temperature and oxidative stress; it is the most common surgically correctable cause of male subfertility.
• Cryptorchidism. An undescended testis sits at core temperature, impairing spermatogenesis and raising germ-cell tumour risk; early orchidopexy mitigates both.
• Gonadotoxins. Alkylating chemotherapy and radiation kill dividing spermatogonia; sperm banking before treatment is standard counselling.
• Heat. Hot tubs, prolonged laptop use, and febrile illness transiently depress counts, recovering over the next spermatogenic cycle.

Spermatogenesis vs oogenesis

Both processes use meiosis to halve the chromosome number, but almost everything else differs — and those differences explain key facts of human reproduction and genetics.

Feature	Spermatogenesis	Oogenesis
Onset	Begins at puberty	Begins before birth (in fetus)
Duration / pattern	Continuous, lifelong, ~64-day cycle	Cyclical; arrests for years to decades
Gametes per precursor	4 functional sperm per spermatocyte	1 egg + 2-3 polar bodies per oocyte
Cytoplasmic division	Equal; minimal cytoplasm retained	Unequal; egg keeps nearly all cytoplasm
Reserve	Self-renewing stem cells; no fixed limit	Finite follicle pool, declines with age
Output	~100-300 million/day	~1 mature egg per cycle
Dominant age-related error	De novo point mutations rise with paternal age	Aneuploidy rises with maternal age

The continuous, division-heavy nature of spermatogenesis is why de novo single-nucleotide mutations accumulate with paternal age — each round of stem-cell replication risks a copying error. The decades-long arrest of oogenesis, by contrast, lets cohesion proteins holding chromosomes together degrade, so non-disjunction and trisomies climb with maternal age. Same biochemical machinery, opposite failure modes.

Hormonal control in one paragraph

The hypothalamus fires GnRH in pulses; the pituitary answers with LH and FSH. LH tells Leydig cells to make testosterone; FSH tells Sertoli cells to nurse germ cells and to secrete inhibin B and androgen-binding protein. Testosterone and inhibin B feed back to throttle the hypothalamus and pituitary, holding the system in balance. Disrupt any node — steroids that mute GnRH, a pituitary tumour, a damaged testis — and the downstream sperm count falls. Measuring FSH, LH, testosterone, and inhibin B together localises a fertility problem the way a circuit diagram localises a fault.

This article is educational and is not medical advice. Fertility concerns, abnormal semen analyses, and hormone therapy should be evaluated by a qualified clinician.